7Baggers
 (anab) movement within algorithmic entry frameworks  news.stocktradersdaily.com Sat, 15 Nov 2025 17:46:02 GMT
 HC Wainwright Increases Earnings Estimates for AnaptysBio  MarketBeat Fri, 14 Nov 2025 15:58:38 GMT
 Leerink Partnrs Increases Earnings Estimates for AnaptysBio  MarketBeat Fri, 14 Nov 2025 15:58:38 GMT
 anaptysbio shares plunge following clinical trial failure  AD HOC NEWS Fri, 14 Nov 2025 06:05:05 GMT
 What is Wedbush's Forecast for AnaptysBio Q1 Earnings?  MarketBeat Thu, 13 Nov 2025 14:26:48 GMT
 What is HC Wainwright's Estimate for AnaptysBio Q1 Earnings?  MarketBeat Thu, 13 Nov 2025 14:26:48 GMT
 AnaptysBio to Establish Separate Royalty Management, Pharma Development Cos.  San Diego Business Journal Wed, 12 Nov 2025 13:01:01 GMT
 AnaptysBio (NASDAQ:ANAB) Shares Gap Down - What's Next?  MarketBeat Tue, 11 Nov 2025 19:39:12 GMT
 truist financial maintains anaptysbio(anab.us) with hold rating  富途牛牛 Tue, 11 Nov 2025 13:31:00 GMT
 AnaptysBio (ANAB) Rating Maintained as HC Wainwright Lowers Pric  GuruFocus Tue, 11 Nov 2025 12:09:48 GMT
 AnaptysBio price target lowered to $70 from $83 at Barclays  TipRanks Tue, 11 Nov 2025 11:23:36 GMT
 Why AnaptysBio Stock Plummeted, Reversing A 70% Monthlong Run  Investor's Business Daily Mon, 10 Nov 2025 21:53:00 GMT
 why this biotech stock just reversed a 70% monthlong run  Investor's Business Daily Mon, 10 Nov 2025 21:53:00 GMT
 AnaptysBio price target raised to $36 from $20 at Truist  TipRanks Mon, 10 Nov 2025 16:06:13 GMT
 AnaptysBio abandons rosnilimab for ulcerative colitis after phase 2 fail  Fierce Biotech Mon, 10 Nov 2025 15:05:20 GMT
 anaptysbio abandons rosnilimab for uc after phase 2 fail  Fierce Biotech Mon, 10 Nov 2025 15:05:20 GMT
 AnaptysBio stock tumbles after discontinuing ulcerative colitis trial  Investing.com Mon, 10 Nov 2025 14:57:52 GMT
 AnaptysBio Announces Discontinuation of Rosnilimab UC Trial  TradingView Mon, 10 Nov 2025 14:15:00 GMT
 anaptysbio (anab) halted, news pending  StreetInsider Mon, 10 Nov 2025 13:58:37 GMT
 Analysts Offer Predictions for AnaptysBio FY2025 Earnings  MarketBeat Sat, 08 Nov 2025 08:00:00 GMT
 Wall Street Zen Upgrades AnaptysBio (NASDAQ:ANAB) to "Buy"  MarketBeat Sat, 08 Nov 2025 08:00:00 GMT
 Wedbush Has Bearish Forecast for AnaptysBio FY2025 Earnings  MarketBeat Sat, 08 Nov 2025 08:00:00 GMT
 AnaptysBio FY2025 EPS Forecast Increased by HC Wainwright  MarketBeat Sat, 08 Nov 2025 08:00:00 GMT
 AnaptysBio (NASDAQ:ANAB) Trading Up 11.9% After Analyst Upgrade  MarketBeat Fri, 07 Nov 2025 08:00:00 GMT
 Decoding AnaptysBio Inc (ANAB): A Strategic SWOT Insight  GuruFocus Fri, 07 Nov 2025 05:18:47 GMT
 why anaptysbio inc. stock remains resilient - take profit & daily stock trend watchlist  Fundação Cultural do Pará Thu, 06 Nov 2025 01:48:48 GMT
 Guggenheim Raises Price Target for AnaptysBio (ANAB) to $100 | A  GuruFocus Wed, 05 Nov 2025 15:47:36 GMT
 wells fargo maintains overweight rating on anaptysbio (anab), ra  GuruFocus Wed, 05 Nov 2025 15:47:36 GMT
 AnaptysBio’s Windfall From GSK Puts It Back In The Black  Finimize Wed, 05 Nov 2025 12:21:27 GMT
 anaptysbio reports q3 2025 results and strategic plans  TipRanks Wed, 05 Nov 2025 05:00:42 GMT
 td cowen maintains anaptysbio(anab.us) with buy rating  富途牛牛 Wed, 05 Nov 2025 03:32:00 GMT
 anaptysbio reports q3 eps 52c vs ($1.14) last year  TipRanks Tue, 04 Nov 2025 22:10:33 GMT
 Anaptys Announces Participation in November Investor Conferences  GlobeNewswire Tue, 04 Nov 2025 21:15:00 GMT
 anab - anaptysbio inc latest stock news & market updates  Stock Titan Tue, 04 Nov 2025 21:15:00 GMT
 AnaptysBio Reports Q3 2025 Results and Strategic Plans  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 AnaptysBio Q3 collaboration revenue jumps on GSK's Jemperli sales  TradingView Tue, 04 Nov 2025 08:00:00 GMT
 anaptysbio, inc. (anab) surpasses q3 earnings and revenue estimates  Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
 AnaptysBio FY2026 EPS Estimate Boosted by Leerink Partnrs  MarketBeat Mon, 03 Nov 2025 08:00:00 GMT

AnaptysBio, Inc
(NASDAQ:ANAB) 

ANAB stock logo

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. The company's products include Imsidolimab, an IL-36R antibody that inhibits the interleukin-36 receptor for the treatment of various derma...

Founded: 2005
Full Time Employees: 89
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends